|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-4-15
|
|
pubmed:abstractText |
Medication adherence may be a proxy for healthy behaviors and other factors that affect outcomes. Prior studies of the association between placebo adherence and health outcomes have been limited primarily to men enrolled in clinical trials and cardiovascular disease outcomes. We examined associations between adherence to placebo and the risk of fracture, coronary heart disease, cancer, and all-cause mortality in the 2 Women's Health Initiative hormone therapy randomized trials.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/,
http://linkedlifedata.com/resource/pubmed/grant/24152,
http://linkedlifedata.com/resource/pubmed/grant/32100-2,
http://linkedlifedata.com/resource/pubmed/grant/32105-6,
http://linkedlifedata.com/resource/pubmed/grant/32108-9,
http://linkedlifedata.com/resource/pubmed/grant/32111-13,
http://linkedlifedata.com/resource/pubmed/grant/32115,
http://linkedlifedata.com/resource/pubmed/grant/32118-32119,
http://linkedlifedata.com/resource/pubmed/grant/32122,
http://linkedlifedata.com/resource/pubmed/grant/42107-26,
http://linkedlifedata.com/resource/pubmed/grant/42129-32,
http://linkedlifedata.com/resource/pubmed/grant/44221,
http://linkedlifedata.com/resource/pubmed/grant/95364,
http://linkedlifedata.com/resource/pubmed/grant/AG027400,
http://linkedlifedata.com/resource/pubmed/grant/AR 053351,
http://linkedlifedata.com/resource/pubmed/grant/N01WH22110
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1537-1948
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
427-35
|
|
pubmed:dateRevised |
2011-8-23
|
|
pubmed:meshHeading |
pubmed-meshheading:21422960-Cause of Death,
pubmed-meshheading:21422960-Estrogen Replacement Therapy,
pubmed-meshheading:21422960-Female,
pubmed-meshheading:21422960-Hip Fractures,
pubmed-meshheading:21422960-Humans,
pubmed-meshheading:21422960-Medication Adherence,
pubmed-meshheading:21422960-Middle Aged,
pubmed-meshheading:21422960-Mortality,
pubmed-meshheading:21422960-Myocardial Infarction,
pubmed-meshheading:21422960-Neoplasms,
pubmed-meshheading:21422960-Placebo Effect,
pubmed-meshheading:21422960-Placebos,
pubmed-meshheading:21422960-Proportional Hazards Models,
pubmed-meshheading:21422960-Randomized Controlled Trials as Topic,
pubmed-meshheading:21422960-Risk Factors,
pubmed-meshheading:21422960-Time Factors,
pubmed-meshheading:21422960-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials.
|
|
pubmed:affiliation |
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 1530 3rd Ave South, FOT 805D, Birmingham, AL 35294, USA. jcurtis@uab.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
